Clinical features and endovascular treatment of intracranial arteriovenous malformations in pediatric patients
- 526 Downloads
The purpose of this study was to characterize clinical features and evaluate the clinical outcome of endovascular embolization treatment intracranial arteriovenous malformations in pediatric patients.
A cohort of children (age ≤ 18 years) with arteriovenous malformations (AVMs) from 2000 to 2012 was included. Predictors studied included patient gender, age, and angioarchitectural features, including AVM location, nidus morphology and size, venous drainage, and associated aneurysms. Treatment method, complications and outcomes were recorded. The features of AVMs were evaluated before the treatment.
One hundred twenty-seven children (77 males, mean age 13.2 years) were included; 90/127 (70.9 %) children were presented with hemorrhage. AVM size and deep venous drainage were independently associated with hemorrhage; 66/127 patients (52 %) treated with endovascular embolization. Complete obliteration at the end of all endovascular procedures was achieved in 14/66 patients (21.2 %), with an average of 78 % (range, 20–100 %) volume reduction. A mean of 2.9 (range, 1–9) feeding pedicles was embolized per patient. Overall, nine complications occurred in a total of 123 procedures (7.3 %). There was no procedure-related death in this study population. There was no significant difference between patients with and without complications in terms of AVM grade, demographic characteristics, or embolization features.
AVM size and deep venous drainage were independently associated with hemorrhage in pediatric patients. Endovascular procedure is feasible and safe for pediatric AVMs, and complete embolization can be achieved in small AVMs, while large AVMs can be adequately reduced in size for additional microsurgery or stereotactic radiosurgery.
KeywordsArteriovenous malformations Pediatric Endovascular treatment Outcome Obliteration
Conflict of interest/disclosures
The authors declare that they have no financial or other conflicts of interest in relation to this research and its publication.
- 1.n-BCA Trail Investigators (2002) N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 23: 748–755Google Scholar
- 11.Hoh BL, Ogilvy CS, Butler WE, Loeffler JS, Putman CM, Chapman PH (2000) Multimodality treatment of nongalenic arteriovenous malformations in pediatric patients. Neurosurgery 47(346–357):357–358Google Scholar
- 14.Jahan R, Murayama Y, Gobin YP, Duckwiler GR, Vinters HV, Vinuela F (2001) Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 48(984–995):995–997Google Scholar
- 16.Kiris T, Sencer A, Sahinbas M, Sencer S, Imer M, Izgi N (2005) Surgical results in pediatric Spetzler–Martin grades I–III intracranial arteriovenous malformations. Childs Nerv Syst 21(69–74):75–76Google Scholar
- 26.van Rooij WJ, Sluzewski M, Beute GN (2007) Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 28(172–177):178Google Scholar